Breaking the Fifty-Year Anaemia Deadlock

Breaking the Fifty-Year Anaemia Deadlock: A Clinical and Policy Roadmap for AMB 2.0 in India:

For more than five decades, India has waged a continuous, well-funded war against nutritional anaemia, yet the needle on the population dial has barely budged. If a medical historian were to trace the policy timeline from 1970 to the present, they would see an impressive succession of flagship initiatives: the National Nutritional Anaemia Prophylaxis Programme (NNAPP) launched in 1970, the National Nutritional Anaemia Control Programme (NNACP) in 1991, the Weekly Iron and Folic Acid Supplementation (WIFS) programme in 2012, the National Iron Plus Initiative (NIPI) in 2013, and finally the revamped Anaemia Mukt Bharat (AMB) strategy launched in 2018 under POSHAN Abhiyaan,which subsequently transitioned into AMB 2.0 under Mission Poshan 2.0 (1,2).

Across every single one of these avatars, the core operational belief remained largely the same: Indian anaemia is overwhelmingly caused by dietary iron scarcity, and handing out millions of Iron and Folic Acid (IFA) tablets and syrups across the life cycle will eventually wipe it out.

Yet when the data from the fifth National Family Health Survey (NFHS-5, 2019–21) arrived, they delivered a sobering reality check. Instead of falling by the targeted three percentage points per year under AMB, anaemia prevalence actually climbed across every demographic cohort compared to NFHS-4 (2015–16) (3). Childhood anaemia (6–59 months) rose from 58.6% to 67.1%; adolescent girls (15–19 years) increased from 54.1% to 59.1%; women of reproductive age (15–49 years) rose from 53.1% to 57.0%; and pregnant women remained above 52.2% (3). Even as administrative dashboards showed overall IFA supplementation coverage rising from 35.5% in 2018–19 to 57.6% by 2022–23 (4), the biological burden at the community level remained stubbornly stagnant.

Breaking this fifty-year deadlock requires an honest clinical post-mortem of why previous programmes fell short, what our landmark surveys are actually telling us, and what concrete, field-ready actions can finally turn the tide.

Why Have Five Decades of Programmes Stagnated? The Four Structural Blind Spots

Before designing new interventions, we have to confront why NNAPP, NIPI, and the initial phase of AMB struggled to translate supply-chain numbers into higher haemoglobin levels.

1. The Measurement Mirage: Capillary Blood vs. Venous Reality Part of India's apparent stagnation—and the dramatic discrepancy between surveys—lies in how we draw blood in the field. Large household surveys like the NFHS rely on a single drop of capillary blood squeezed from a finger-prick (or heel-prick in infants) and tested on portable photometers (HemoCue) (3,5). In contrast, the Comprehensive National Nutrition Survey (CNNS, 2016–18)collected venous blood analysed in gold-standard automated haematology laboratories (6). The difference was startling:CNNS reported anaemia in 40.5% of preschool children (1–4 years), 23.5% of school-age children (5–9 years), and 28.4% of adolescents (10–19 years)—nearly twenty-five percentage points lower than NFHS estimates (6,7). When frontline workers "milk" a finger to get a drop of blood, interstitial tissue fluid dilutes the red cells, artificially lowering haemoglobin readings by 0.5 to 1.2 g/dL and inflating national prevalence figures (5,8). Recognising this methodological distortion, the Indian Council of Medical Research (ICMR) subsequently initiated the Diet and Biomarker Survey in India (DABS-I) and recommended shifting survey protocols away from capillary finger-pricks toward venous sampling (8).

2. The "Iron-Only" Fallacy in a Multi-Etiology Landscape Even when venous blood is used, millions of Indian women and children remain genuinely anaemic. However, the biggest scientific flaw of legacy programmes was treating "anaemia" as a synonym for "iron deficiency." When Anura Kurpad, Harshpal Singh Sachdev, and colleagues analysed the CNNS venous biomarker dataset alongside the global BRINDA (Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia) framework, they uncovered a pivotal epidemiological truth: isolated iron deficiency accounts for less than a third of anaemia among Indian children and adolescents (6,7,9). Specifically, in the CNNS cohort, 31.9% of anaemic preschoolers had folate or vitamin B12 deficiency without iron deficiency, roughly 25% to 30% suffered from anaemia of chronic inflammation or unknown etiology, and a substantial proportion carried genetic haemoglobinopathies (such as beta-thalassemia trait, sickle cell trait, or HbE) (7). Giving a high-dose 60 mg elemental iron tablet to a teenager whose anaemia is caused by vitamin B12 deficiency, chronic gut inflammation, or thalassemia minor does zero good—and can actively cause harm (7,10).

3. The Supply-to-Swallowing Gap in AMB 1.0 Under the 6x6x6 strategy of Anaemia Mukt Bharat (targeting six beneficiary groups through six interventions and six institutional mechanisms), massive energy went into procuring and distributing IFA tablets. Although AMB rightly reduced the prophylactic elemental iron dose for women and adolescents from 100 mg to 60 mg and introduced sugar-coated tablets to reduce metallic aftertaste (1), field implementation studies consistently highlight a chasm between distribution and consumption (4,11). Pediatric auto-dispensing IFA syrup bottles frequently ran out of stock or suffered from unpalatable taste and staining of teeth; school-based WIFS distribution broke down during holidays or among out-of-school adolescents; and pregnant women routinely discarded unconsumed blister packs due to epigastric burning, nausea, constipation, and black stools because frontline workers lacked time to counsel them on managing side effects (11).

4. The Weakest Pillars of the 6x6x6 ArchitectureLook at the six interventions of AMB: (i) prophylactic IFA supplementation, (ii) bi-annual deworming, (iii) intensified behaviour change communication and delayed cord clamping, (iv) digital testing and point-of-care treatment, (v) mandatory food fortification in public programmes, and (vi) addressing non-nutritional causes (malaria, fluorosis, haemoglobinopathies) (1,4). On the ground, Pillars 1, 2, and 5 absorbed almost all administrative monitoring, while Pillar 4 (accurate point-of-care diagnostics) and Pillar 6 (non-nutritional causes) remained severely neglected across primary health centres (4,12).

Eight Doable, Evidence-Based Actions to Mitigate India's Anaemia Burden

Moving from AMB 1.0 to an effective AMB 2.0 requires shifting from a mechanical "pill-distribution drive" to an etiology-driven clinical and public health strategy. The following eight actionable reforms can be implemented immediately within India's existing health and nutrition infrastructure:

Action 1: Upgrade from Blind "Test and Treat" to an Etiology-Driven Algorithm Under current field practice, any child, adolescent, or pregnant woman with low haemoglobin is automatically placed on therapeutic oral iron, and if their haemoglobin fails to rise after four to आठ weeks, they are simply labelled "non-compliant". In late 2026, the Indian Council of Medical Research published a landmark policy-informed Treatment and Tracking Algorithm for Iron Deficiency Anaemia to fix this exact gap (12).

• What to do: Establish a mandatory "4-Week Non-Responder Protocol" at all Community Health Centres (CHCs) and block primary health centres. If a patient's haemoglobin does not increase by at least 1 g/dL after four weeks of supervised oral therapy, stop blind iron escalation. Perform a basic Complete Blood Count (CBC) using existing block-level 3-part or 5-part automated haematology analysers (checking Mentzer Index via MCV and RBC count to rule out thalassemia trait), alongside a point-of-care C-reactive protein (CRP) and serum ferritin test (12). This immediately separates true iron-deficiency responders from those with haemoglobinopathies, chronic inflammation, or B12/folate deficiency.

Action 2: Reformulate Supplements and Align Dosing with Hepcidin Biology Oral iron absorption is tightly governed by the hepatic hormone hepcidin. When a woman swallows a heavy 60 mg elemental iron tablet in the morning, her liver responds with an acute surge in circulating hepcidin that persists for 24 to 48 hours, blocking intestinal ferroportin channels (12,13). If she takes a second tablet that evening—or even the next morning—up to 85% to 90% of that iron sits unabsorbed in her gut lumen, generating free radicals, irritating the gastric mucosa, and feeding pathogenic colonic bacteria (10,13).

• What to do: First, revise clinical therapeutic guidelines for mild-to-moderate iron deficiency anaemia in non-pregnant women and adolescents to leverage morning, alternate-day oral dosing (or single morning dosing synced with diurnal hepcidin troughs), which clinical trials show yields superior fractional iron absorption and cuts gastrointestinal side effects by half compared to twice-daily dosing (12,13). Second, transition antenatal supplementation in vitamin B12-deficient belts from isolated IFA to the WHO-recommended United Nations Multiple Micronutrient Antenatal Preparation (UNIMMAP) or reformulated IFA-plus-B12/vitamin C tablets so that red blood cell maturation isn't stalled by hidden cobalamin scarcity (7).

Action 3: Standardize Venous and Auto-Analyser Diagnostics at the Sub-District Level We cannot manage a clinical condition if our rulers are bent. Relying on Sahli’s acid haematin tubes or poorly calibrated capillary finger-prick photometers at sub-centres creates massive false-positive treatment burdens while missing severely anaemic mothers (5,8).

• What to do: Enforce the AMB guideline mandating semi-automated or automated haematology analysers using venous blood samples at all Primary Health Centres (PHCs) and block facilities for antenatal check-ups (1,5). For outreach Village Health, Sanitation and Nutrition Days (VHSNDs), strict standard operating procedures must prohibit "milking" the finger during capillary pricks (collecting only the third free-flowing drop after wiping away the first two) and mandate quarterly calibration of digital haemoglobinometers against block-level venous auto-analysers (5,8).

Action 4: Scale Up Safe Intravenous Ferric Carboxymaltose (FCM) for Moderate-to-Severe Antenatal AnaemiaWhen a rural pregnant woman registers for antenatal care late in her second or early third trimester with a haemoglobin of 7.8 g/dL, oral iron tablets simply cannot rebuild her haemoglobin and iron stores fast enough before delivery—especially if she suffers from pregnancy-induced nausea. While AMB guidelines include parental iron sucrose,traditional intravenous iron sucrose requires four to six separate hospital visits across two weeks, leading to massive drop-out rates among daily-wage rural mothers (1).

• What to do: Decentralize and guarantee supply-chain availability of single-dose Intravenous Ferric Carboxymaltose (FCM) at all First Referral Units (FRUs), CHCs, and 24x7 PHCs. A single 15-to-20-minute drip of FCM can safely deliver up to 1,000 mg of elemental iron in one outpatient visit during the second or third trimester, reliably boosting haemoglobin by 1.5 to 2.5 g/dL within three weeks and slashing postpartum haemorrhage morbidity without requiring repeated loss of daily wages.

Action 5: Rebalance the Fortification Strategy Toward Whole-Food Dietary Diversity Under AMB and Mission Poshan 2.0, the government scaled up the distribution of rice fortified with iron, folic acid, and vitamin B12 across the Public Distribution System (PDS), PM POSHAN, and ICDS. While fortified staples provide a baseline safety net,nutrition scientists led by Anura Kurpad and colleagues have cautioned against simultaneously layering mandatory chemical iron fortification across rice, wheat, salt, and oil without biomarker surveillance—noting risks of excess unabsorbed colonic iron, gut dysbiosis, and oxidative stress in non-iron-deficient populations or thalassemia carriers (10).

• What to do: Cap chemical fortification to a single staple vehicle per region and accompany it with sentinel biomarker monitoring of serum ferritin and CRP (10). Simultaneously, redirect ICDS and PM POSHAN budgets toward bioavailable whole foods and dietary absorption enhancers (14): adding boiled eggs, sprouted local pulses, roasted sattu or groundnut-sesame chikki, and dark green leafy vegetables to school and Anganwadi meals, paired with a mandatory squeeze of lemon, amla (Indian gooseberry), or seasonal guava after meals (14).Ascorbic acid (vitamin C) from a simple amla or lemon wedge reduces dietary ferric iron to ferrous iron in the duodenum, multiplying non-heme iron absorption three- to four-fold by neutralising the phytate locks in cereal-heavy Indian meals (14). Equally simple is counselling households to keep a 60-minute gap between meals and tea or coffee, preventing polyphenols and tannins from chelating dietary iron in the stomach (14).

Action 6: Enforce the "Zero-Cost" Birth Intervention—Delayed Umbilical Cord Clamping The most cost-effective intervention against infant anaemia requires zero tablets, zero electricity, and zero supply chains, yet remains inconsistently practiced in busy labour rooms. Clamping a newborn's umbilical cord immediately after birth leaves up to a third of the feto-placental blood volume trapped in the placenta.

• What to do: Make Delayed Umbilical Cord Clamping (waiting 1 to 3 minutes after birth, or until cord pulsations cease) a mandatory, audited quality indicator on every labour-room checklist under the LaQshyaprogramme across both public and private maternity facilities. Allowing placental transfusion to complete transfers an extra 80 to 100 mL of blood—delivering 40 to 50 mg/kg of iron directly into the newborn's circulation, which protects the infant against iron deficiency for the first four to six months of life (1).

Action 7: Operationalize Pillar 6—Integrate WASH, Malaria, Fluorosis, and Sickle Cell Missions As long as a child drinks contaminated water and suffers recurrent bouts of subclinical environmental enteropathy, elevated hepatic hepcidin will block whatever oral iron we pour into their mouth (9). Similarly, in tribal and endemic belts of Central and Eastern India, malaria parasites, high groundwater fluoride (which damages duodenal microvilli and bone marrow erythropoiesis), and sickle cell/thalassemia traits drive huge proportions of refractory anaemia (1,7).

• What to do: Break the operational silos between vertical health programmes. Link AMB sub-centre registries directly with the National Sickle Cell Anaemia Elimination Mission, the National Vector Borne Disease Control Programme, and the Jal Jeevan Mission. In fluorosis-endemic blocks, providing defluoridated piped water reverses refractory anaemia faster than doubling iron pills; in tribal blocks, screening adolescents with solubility/HPLC point-of-care tests prevents iron overload in carriers of haemoglobinopathies.

Action 8: Shift Frontline Incentives from "Stock Distributed" to "Verified Compliance and Cure"Right now, the AMB Index ranks states and districts primarily on the percentage of target beneficiaries who were handed IFA supplements (4). What gets measured gets done: workers hand out strips of pills to hit monthly targets, while strips pile up behind kitchen jars.

• What to do: Restructure ASHA and ANM performance-linked incentives around "Test-Treat-Track" closure loops rather than raw pill distribution (12). Use the Poshan Tracker and RCH portal to incentivise frontline workers when an anaemic adolescent girl or pregnant woman completes 90 days of verified therapy anddemonstrates a documented rise in haemoglobin at follow-up testing—turning frontline workers from pill couriers into true community health navigators.

The Way Forward

India does not suffer from a shortage of political will or iron tablets; it suffers from a mismatch between a complex,multi-factorial biological problem and a fifty-year-old, single-nutrient operational hammer. By aligning our diagnostics with venous standards, tailoring treatment to actual underlying etiologies, respecting the physiology of hepcidin, and putting diverse, vitamin-C-rich whole foods back onto the everyday thali, Anaemia Mukt Bharat can finally move from a distant policy slogan to a measurable biological reality.

References

1. Ministry of Health and Family Welfare, Government of India. Anemia Mukt Bharat: Intensified National Iron Plus Initiative (I-NIPI) Operational Guidelines for Programme Managers. New Delhi: MoHFW; 2018.
2. Kapil U, Kapil R, Gupta A. National Iron Plus Initiative: current status and future strategy. Indian J Med Res.2019;150(3):239–47.
3. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-5), 2019–21: India Report. Mumbai: IIPS; 2021.
4. Joe W, Rinju, Patel N, Alambusha R, Kulkarni B, Yadav K, et al. Coverage of iron and folic acid supplementation in India: progress under the Anemia Mukt Bharat strategy 2017–20. Health Policy Plan. 2022;37(5):597–606.
5. Neufeld LM, Larson LM, Kurpad A, Mburu S, Martorell R, Brown KH. Hemoglobin concentration and anemia diagnosis in venous and capillary blood: biological basis and policy implications. Ann N Y Acad Sci.2019;1450(1):172–89.
6. Ministry of Health and Family Welfare, Government of India, UNICEF, Population Council. Comprehensive National Nutrition Survey (CNNS) National Report. New Delhi: MoHFW; 2019.
7. Sarna A, Porwal A, Ramesh S, Agrawal PK, Acharya R, Johnston R, et al. Characterisation of the types of anaemia prevalent among children and adolescents aged 1–19 years in India: a population-based study. Lancet Child Adolesc Health. 2020;4(7):515–25.
8. Sachdev HS, Kurpad AV, Saxena R, Kapil U. Need for revising the methodology for estimating the prevalence of anaemia in national surveys in India. Indian J Med Res. 2021;154(6):769–72.
9. Suchdev PS, Namaste SM, Aaron GJ, Raiten DJ, Brown KH, Flores-Ayala R, et al. Overview of the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) Project. Adv Nutr. 2016;7(2):349–56.
10. Kurpad AV, Ghosh S, Thomas T, Bandyopadhyay S, Goswami R, Gupta A, et al. Perspective: When the cure might become the malady: the layering of multiple interventions with mandatory micronutrient fortification of foods in India. Am J Clin Nutr. 2021;114(4):1261–6.
11. Rai RK, Bromage S, Fawzi WW. Receipt of weekly iron supplementation among Indian children, 2005–2016.Curr Dev Nutr. 2021;5(3):nzab019.
12. Kulkarni B, Sinha S, Pullakhandam R, Nair KM, Sachdev HS, et al. Treatment and tracking algorithm for iron deficiency anaemia among children and adolescents—a policy informed evidence-based framework for India.Indian J Med Res. 2026;164:729–35.
13. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol.2017;4(11):e524–33.
14. Indian Council of Medical Research – National Institute of Nutrition. Dietary Guidelines for Indians. Hyderabad:ICMR-NIN; 2024.